Explore every episode of the podcast Trending Health

Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s Pharma Customer Engagement to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Customer Experience Transformation Lead, Mike Zapiec, and Head of Life Sciences, Karen Baldry to share what they learned about effectively engaging customers. 

For more information about Vynamic’s work in Customer Experience Transformation, visit: https://vynamic.com/what-we-do/services/customer-experience-transformation-cxt/ 

Podcast Tags: healthcare, life sciences, customer experience, omnichannel 

Panel – Mike Zapiec, Karen Baldry, Jen Burke 

Research & Production – Mike Zapiec, Karen Baldry, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026, it’s clear that theorized implications from the Inflation Reduction Act are becoming realities for the life sciences industry. In this episode, Jen and Mindy are joined by Putnam Associates Partner, Scott Briggs, to explore how companies can navigate the new pricing pressures and negotiation frameworks while continuing to innovate and ensure patient access to critical therapies.

For more information about Putnam’s work in Value, Pricing and Access, visit their website: https://www.putassoc.com/our-expertise/value-pricing-access/

For more information about Vynamic’s work in Market Access, visit: https://vynamic.com/what-we-do/health-industry/life-sciences/market-access/

Podcast Tags: healthcare, life sciences, product launch, market access, drug pricing, life sciences trends

Panel – Scott Briggs, Mindy McGrath, Jen Burke

Research & Production – Scott Briggs, Mindy McGrath, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

With increasing pressure to bring products to market faster than ever, Life Sciences companies need to balance supply chain speed with global complexities, regulatory hurdles, and digital integration to maintain competitiveness. In this episode, Jen is joined by Vynamic’s Dan Ahern and Roche Product Strategy Leader within Global Supply Chain, Devon Blackburn, to discuss how pharmaceutical companies are embracing change to drive launch success.

Disclaimer: Devon is sharing his own opinions, which might not necessarily reflect the perspective of Roche.

Podcast Tags: healthcare, life sciences, product launch, supply chain, life sciences trends

Panel – Devon Blackburn, Dan Ahern, Jen Burke

Research & Production – Devon Blackburn, Dan Ahern, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Organizational AI adoption has dramatically increased over the years largely due to generative AI, leaving organizations to navigate challenges while rapidly scaling and adopting new technologies. In this episode, Jen is joined by Vynamic’s Chris Wuenschel & Frank Longo, as well as AI Mobilization Offering Lead, Todd Quartiere, to discuss their experiences with different factors that can make or break AI transformation programs.

To learn more about implementing AI within your organization, check out the AI At Vynamic page on Vynamic’s website for more information.

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT, tech transformation, digital transformation, life sciences 

Source Links: 

• The state of AI in early 2024: Gen AI adoption spikes and starts to generate value 

Panel – Jen Burke, Todd Quartiere, Chris Wuenschel, Frank Longo 

Research & Production – Everly Petruzzelli  

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In today’s competitive and dynamic pharmaceutical landscape, mastering the art of brand planning and management is crucial to success. In this episode, Jen and Mindy are joined by Vynamic’s Brand Strategy Offering Lead, Liza Flaherty, to discuss common challenges, best practices, and latest trends impacting the process of creating an effective brand plan.  

For our listeners, if you want to learn more about Vynamic’s Brand Strategy offering and brand planning capabilities, please email Liza.Flaherty@vynamic.com or visit our website for more information. 

Podcast Tags: healthcare, life sciences, product launch, brand planning, life sciences trends 

Source Links: 

• The Essential Guide to Creating and Implementing a Successful Pharmaceutical Brand Plan 
• Navigating the Inflation Reduction Act’s Impact on Drug Pricing and Innovation 
• The Inflation Reduction Act: the Undoing of Pharma Marketing or a Catalyst for Innovation?. 
• Go-to-Market Strategy for Pharmaceuticals 
• Reimagining the Brand Planning Process in Healthcare 

Panel – Jen Burke, Mindy McGrath, Liza Flaherty 

Research & Production – Liza Flaherty, Adrea Cope & Everly Petruzzelli  

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic’s Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris as well as special guests, CodeScience’s CEO, Mike Utell, and Chief Revenue Officer, Sean Hogan, to discuss how Life Sciences leaders should approach this decision and transition to minimize disruption and maximize business value.

For more information about CodeScience, visit their website:   

For more information about Vynamic’s work in Commercial Operations and Tech & Digital Transformation, visit:   

Podcast Tags: healthcare, life sciences, healthcare technology, healthcare news, Veeva, Salesforce, tech and digital transformation, CRM, commercial operations, CodeScience 

Panel – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris, Mike Utell, Sean Hogan 

Research & Production – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the Supreme Court’s overturning of Chevron Deference and what this will mean for the health industry, as well as strategic shifts made by Walgreens under their new CEO, and the ongoing impact of Microsoft’s global IT outage on health systems, hospitals, and clinics.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, Chevron Deference, Walgreens, pharma, pharmacy, CrowdStrike, Microsoft, IT outage 

Source Links: 

• Health Care Impacts Following Chevron Decision 
• Supreme Court overrules Chevron deference, dealing blow to federal healthcare agencies 
• After Billions in Losses, Walgreens Doesn’t Want to Own VillageMD 
• Walgreens slashes profit guidance with plans to close more pharmacy stores, cut stake in VillageMD 
• Impacts from global IT outage 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

One of the advantages of serving clients across multiple geographies is that Vynamic can see firsthand how the differences in health systems play out in terms of spend, outcomes, and innovation. Jen & Ryan are joined by Vynamic London’s Oliver White to discuss key differences between the health systems in each country and what they can learn from one another as they move healthcare delivery out of the hospital and into the community setting. In one sense, the US and UK represent two extremes on the delivery system spectrum: the US has the largest private sector system globally while the UK has the largest publicly funded system. They also differ in key metrics around healthcare spend and outcomes (01:19), science and technology (04:21), and wait times for elective procedures and emergency care (06:21). Despite these differences, both systems are focused on improving cost and customer satisfaction – especially when it comes to telehealth and home care (09:05). One model the NHS has put forward in this effort is Community Crisis Response Teams (12:38) – a model that could be attractive as US health systems look to transition care to the home and alleviate emergency department (ED) volumes (15:13). While implementing such a model could present scaling challenges in the US market (16:45), it could also offer opportunities for health plans and providers to improve quality, outcomes, and patient satisfaction (18:29).

Podcast Tags: healthcare, providers, health plans, public health, NHS, CMS, telehealth, crisis care

Source Links:

· https://www.usnews.com/news/healthiest-communities/articles/2019-12-11/survey-finds-fragmented-us-health-care-impedes-coordination-among-providers

· https://www.commonwealthfund.org/international-health-policy-center/countries/england

· https://www.commonwealthfund.org/international-health-policy-center/countries/united-states

· https://www.commonwealthfund.org/blog/2018/what-can-us-and-england-learn-each-others-health-care-reforms

· https://www.healthcareadministration.com/brief-comparison-uk-healthcare-system-vs-u-s-healthcare-system/#:~:text=While%20both%20systems%20have%20world,tax%20based%20system%20versus%20the

· https://www.england.nhs.uk/community-health-services/urgent-community-response-services/

· https://www.england.nhs.uk/wp-content/uploads/2020/11/B0252-Urgent-community-response-2-hour-and-2-days-standards-guidance-30-November-2020.pdf

· https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465904/

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Oliver White, Director

Oliver.white@vynamic.com

Ryan Hummel, Executive and Head of Provider Sector

ryan.hummel@vynamic.com

Jen Burke, Director and Healthcare Industry Strategist

jen.burke@vynamic.com

The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women’s History Month episode, Jen is joined by Vynamic’s Diana Kuritza, Jen Proietti-Fox and HelloGina’s Daphne Petrich to discuss the latest trends in FemTech and what it could mean for women’s health going forward.

Podcast Tags: healthcare, health tech, women’s health, women’s history month, health equity, digital health

Source Links:

·      Make 2023 the year of prioritizing women’s health

·      2023 PREDICTIONS—THE GOOD, THE BAD, AND THE UGLY

·      European FemTech trends and startups to watch in 2023 | With insights from Essity Ventures

·      What To Expect for Femtech in 2023?

·      Despite 2022’s headwinds, women’s health startups did better than ever before

·      The dawn of the FemTech revolution

·      How FemTech is tackling the female health gap

·      Femtech’s Limited Role in Tackling Healthcare Inequity

For more information on HelloGina please visit, https://www.helloginahealth.com/

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at

1-888-VYNAMIC.

Daphne Petrich, US Business Development Lead at HelloBetter

d.petrich@hellobetter.de

Jen Proietti-Fox, Director

Jen.proietti-fox@vynamic.com

Diana Kuritza, Manager

Diana.kuritza@vynamic.com

Jen Burke, Healthcare Industry Strategist

Jen.Burke@vynamic.com

The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely available. In today’s episode, Jen is joined by Vynamic’s Nick Fletcher and Grace Burtonwood to shine light on the opportunities and challenges psychedelics present to the mental health market.

Podcast Tags: healthcare, life sciences, healthcare news, mental health, psychedelics 

Source Links: 

• WHO Topics: Mental Health
• WHO Fact Sheets: Mental Disorders
• WHO: Global Health Estimates
• Multidisciplinary Association for Psychedelic Studies (MAPS)
• National Institute on Drug Abuse (NIDA)
• Compass Pathways
• BBC – FDA Advisory Committee Vote on MDMA
• FDA Guidance on Clinical Trials with Psychedelic Drugs
• How To Change Your Mind (Michael Pollen) 
• European Medicines Agency (EMA)

Panel – Grace Burtonwood, Jen Burke, Nick Fletcher  

Research & Production – Everly Petruzzelli, Nick Fletcher 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen, Karan, and Ollie discuss recent newsworthy items, including the political shifts taking place across Europe and their potential impact to the pharma sector, as well as the challenges posed by medicine stockpiling and breakthroughs in hemophilia treatment.  

Podcast Tags: healthcare, healthcare news, public health, Labour, pharma, medicine stockpiling, haemophilia, NHS, Novo Nordisk 

Source Links: 

• With Europe facing right turn, how will public health be affected? 
• Pharma responds to 2024 UK General Election 
• Romanian hard-right takes healthcare on the road ahead of EU polls 
• EU elections: a moment for pan-European health 
• New Labour government backs pharma reform in UK 
• Massive stockpiling of medicines increases patient risks, warns EU coalition 
• Czechia slams Germany over drug stockpiling 
• EU plan for medicine stockpile could worsen UK’s record shortages 
• Six EU countries push to end mandatory stockpiling of medicines 
• Haemophilia gene therapy now available to NHS patients 
• Novo Nordisk shares positive results for Mim8 in late-stage haemophilia A trial 
• England, Denmark back CSL’s haemophilia B gene therapy 
• I have £2.6m blood and it has \’cured\’ my haemophilia 

Panel – Jen Burke, Karan Pandya, Ollie May 

Research & Production – Karan Pandya 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

The healthcare industry is in an unprecedented era of change as rapidly advancing technologies, changing consumer expectations, and rising costs force organizations to adapt. With a landscape that is becoming increasingly more competitive, organizations are facing a choice: transform traditional models of healthcare delivery or face the risk of being left behind. Today, Mindy and Jen are joined by Vynamic’s Executive and Head of Health Technology Sector, Mary Virzi, to discuss this call to action and how leaders can ensure that these transformations are successful.

Podcast Tags: healthcare, healthcare technology, transformations, digital transformations, healthcare transformations

Source Links: 

• Digital Transformation in Healthcare in 2024: 7 Key Trends 
• New Chartis survey finds that digital transformation gap is growing among health systems 
• From belief to transformation: Digital market leaders focus on value  
• Top Issues Confronting Hospitals 
• Defining your ‘true north’: A road map to successful transformation 
• Why digital transformation in healthcare is so difficult and long-overdue 
• 2024 and beyond: Will it be economic stagnation or the advent of productivity-driven abundance? 

Panel – Mary Virzi, Mindy McGrath, Jen Burke

Research & Production – Adrea Cope, Everly Petruzzelli 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the recent ruling by the United States Supreme Court on access to the abortion pill mifepristone, the declaration of bankruptcy by the Massachusetts-based Steward Health Care system, and the combination flu and COVID-19 vaccine under development by Moderna.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, abortion, mifepristone, telemedicine, IVF, in vitro fertilization, private equity, hospitals, Steward Health Care, bankruptcy, COVID-19, flu, Moderna, mRNA, vaccines 

Source Links: 

• Supreme Court rejects challenge to abortion pill accessibility 
• The Threat to Abortion Rights You Haven’t Heard of 
• Senate Republicans block bill on women’s right to IVF as Democrats make push on reproductive care 
• Senate GOP Blocks IVF Access Bill as Democrats Press for Political Edge 
• Steward secures funding to run its hospitals through end of June 
• Unpacking Massachusetts’ Steward health system crisis 
• The 3rd Largest Mass Hospital system is in bankruptcy, here is what you need to know 
• Lawmakers seek healthcare and retirement protections for Steward Health Care Workers 
• Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shift to enhance patient interaction and outcomes.

Podcast Tags: healthcare, life sciences, patient engagement, patient centricity, patient outcomes, social media, metrics, innovation

Disclaimer: Nico is sharing his own opinions, which might not necessarily reflect Roche’s perspective

Check out Nico’s profile LinkedIn profile here: https://www.linkedin.com/in/nicorenner/ 

Source Links: 

• Harnessing the Power of Social Media in Pharmaceutical Marketing  
• Pharma and Healthcare Social Media Marketing Market 
• The Relationship Between the Pharmaceutical Industry and Social Media 
• Intelligent Post-launch Patient Support 
• Patient Education on Social Media is not the future… 

Panel – Jack Young, Nico Renner and Jen Burke

Research & Production – Jack Young, Nico Renner and Jen Burke

Recording & Editing –Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.

Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine 

Source Links: 

• Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference 
• ASCO: AstraZeneca\’s Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation 
• ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? 
• ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth 
• At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer 
• What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck 
• Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up 
• Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up 
• ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine 
• Moderna And Merck Advance Cancer Treatment With Promising Vaccine 
• NHS patients in England to be offered trials for world-first cancer vaccine 
• Thousands of cancer patients to trial personalised vaccines 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young, Karan Pandya 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic’s Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern’s Chief Experience Officer, Brian Sturgeon, to discuss how healthcare leaders can plot the course for their AI journey and prioritize their investments to better accelerate their business objectives utilizing AI tools. 

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, tech transformation, digital transformation  

Source Links: 

• The AI Strategy Roadmap: Navigating the stages of value creation | The Microsoft Cloud Blog 
• Introducing: Lantern – A Digital Innovation Consultancy Designed for the Era of AI (youtube.com) 
• A Practical Guide to Enabling AI within your Organization. (youtube.com)   
• Reimagining Technology Consulting for the Era of AI – Lantern (lanternstudios.com) 

Panel – Jen Burke, Vince Annerhed-Harris, Brian Sturgeon 

Research & Production – Everly Petruzzelli, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For more information on Lantern, please visit: Lantern – Microsoft Solutions Partner (lanternstudios.com), Lantern’s LinkedIn Page, Build and Modernize AI Apps – Microsoft Azure Marketplace 

If you want to learn more about implementing AI within your organization, you can check out Vynamic | Tech & Digital Transformation | Health Industry Consulting 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role of ride share apps in healthcare. 

Podcast Tags: healthcare, healthcare news, health policy, drug shortages, Medicare, hospitals, providers, FDA, telehealth, inflation reduction act, IRA, ride share, Lyft, Uber  

Source Links:

• Senators float Medicare program that would offer incentive payments to combat drug shortages   
• Second House panel advances two-year telehealth extension 
• Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits 
• CMS proposes new mandatory organ transplant model for end-stage renal disease 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

During Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister to share what they learned about transformation and operating with impact.

To receive a copy of Vynamic\’s \”Operating with Impact: Topical Transformation Dilemmas and Decisions\” presentation, please email

For more information about Vynamic\’s work in Medical Affairs, please visit

Podcast Tags: healthcare, healthcare news, life sciences, medical affairs, MASS East, Fierce, MSL 

Panel – Gemma Pfister, Jen Burke, Tamaron Bertelli  

Research & Production – Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. 

Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week 

Source Links: 

• ’Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web 
• Huge volume of NHS patient and staff data released by hacker 
• NHS cyber attack: Why stolen medical information is so much more valuable than financial data 
• Cyber attacks are one of the biggest threats facing healthcare systems 
• Government Launches NHS Cyber Security Strategy 
• US tech group Palantir wins lucrative NHS data contract 
• Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract 
• European Commission lays down path to future-proof EU biotechnology 
• Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies 
• Roche agrees $7.1bn deal for Telavant to boost drug pipeline  
• Europe’s biotech innovation in the balance 
• Commission takes action to boost biotechnology and biomanufacturing in the EU 
• Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis 
• EU launches landmark €6.5M study on use of psychedelics to treat mental disorders 
• Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy 
• Psychedelic drug research held back by UK rules and attitudes, say scientists 
• King’s College Psychoactive Trials Group 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Karan Pandya, Jack Young 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.  

To learn more about Vynamic’s work in Product Launch, visit Vynamic’s Product Launch page. To read more on navigating alliance product launches, see Vynamic’s latest insight here.  

PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.  

Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trends

Source Links:

• Product launch challenges and how to overcome them
• Drug launches reflect overall company performance
• TO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging Company
• Revenue of the worldwide pharmaceutical market from 2001 to 2023
• Prices for new US drugs rose 35% in 2023, more than the previous year
• Next in pharma 2024: Reinventing for returns
• The Unbearable Cost of Drug Development
• Understanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical Industry
• FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers

Panel – Jen Burke, Ashley Stanley, Chris Savage, Brian Stamm

Research & Production – Adrea Cope & Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the FDA approval of Rejoyn, the first prescription digital treatment for major depressive disorder. They also discuss the ongoing drug shortage crisis, as well as changes coming out of the Centers for Medicare & Medicaid Services and the impact those decisions will have over the next year.  

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, depression, mental health, digital treatment, drugs, pharmaceuticals, shortages, medications, FDA, CMS, Medicare Advantage, breakthrough technology, medical devices 

Source Links: 

• FDA clears first digital treatment for depression, but experts caution that research is still early 
• Number of ongoing US drug shortages reaches new high, pharmacist group says 
• FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages 
• CMS final rule on broker comp, health equity could shake up Medicare Advantage 
• Medicare official says breakthrough device reimbursement rule coming in early summer 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic’s Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, to discuss where we see health organizations experimenting with AI and what it will take for them to achieve their long-term AI ambitions.

To learn more about implementing AI within your organization, check out our recent insight: Why AI fails or flourishes: The underestimated role of culture.

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT

Source Links:

• The Unexpected Winners of the ChatGPT Generative AI Revolution 
• Generative AI in healthcare: Emerging use for care 
• US healthcare leadership: How to respond and thrive 
• How Can AI Improve Health Care? 
• Envisioning Healthcare in a Post-COVID-19 World 
• Three-quarters of health professionals project widespread AI adoption 
• 5 Key Healthcare Industry Trends to Watch in 2024 
• What Do We Mean When We Talk About “AI Democratisation”? 

Panel – Jen Burke, Michael Hudson, Mindy McGrath, Todd Quartiere

Research & Production – Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.

Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity 

Source Links:

• Dutch hospitals use AI to solve no-show patient problems that cost them millions  
• Cancellations of NHS care are having serious impacts on two-thirds of patients  
• Would charging patients for missed appointments help fund the NHS?  
• GP \’no shows\’ cost Norfolk NHS more than 1m in a one month  
• France planning €5 no-show fees in a bid to improve community healthcare  
• France divided over ‘no-show tax’ for patients failing medical appointments   
• Researchers compile detailed catalog of bacteria living in cancer metastases  
• Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech  
• The key to young onset bowel cancer may be gut bacteria  
• The mystery of microbes that live inside tumours  
• Diversity of Bacteria in Cancer Metastases  
• It’s the Little Things: A Role for Bacteria in Cancer Treatment   
• The UK is missing out on EU collaboration to improve treatment for rare diseases  
• Overcoming the burden of rare diseases in Europe  
• Stronger together in the fight against rare diseases  
• Is Europe on track to be the leader in rare diseases?  
• Right here, right now European public health policies must start giving people living with rare diseases a fair chance  
• New rare diseases action plan on horizon, Europe at turning point  
• Europe needs new 360 rare diseases strategy  

Panel – Jack Young, Jen Burke, Ollie May  

Research & Production – Karan Pandya  

Recording & Editing – Mike Liberto, Rachel Skonecki  

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations. 

Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain 

Source Links: 

• Striving for sustainable drug discovery using Green Chemistry 
• Accelerating the transition to net zero in life sciences 
• Process Digital Twin for Pharma 
• Sanofi harnesses Dassault\’s digital twin tech to optimize production at future vaccine plants 
• Strategies for Sustainability in the Global Pharmaceutical Supply Chain 
• Bayer: Improving Sustainability Practices in the Supply Chain 
• Bayer: Commitments in Action Creating a Sustainable Product Supply 
• Making biopharma’s supply chains more environmentally sustainable 
• The pharma companies working towards supply chain sustainability 
• Carbon footprint of the global pharmaceutical industry and relative impact of its major players 
• The Greenhouse Gas Protocol: Technical Report  
• Understanding pharma’s challenges and opportunities in relation to the climate crisis
• Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies 
• Pharma’s path to Net Zero: Targeting Scope 3 emissions 

Panel – Oliver May, Rosanna Vellacott, Matt O’Dell 

Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May  

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a kidney from a CRISPR gene edited pig was transplanted into a human.

Podcast Tags: healthcare, healthcare news, CVS health, PBMs, biosimilars, 340B, pharmacies, hospitals, providers, xenotransplantation, CRISPR, gene editing

Source Links:

• As Humira biosimilars take over the market, CVS has created a new ploy; the drug “rebate credit”
• Federal appeals court sides with 340B contract pharmacies 
• American Hospital Association 340B Factsheet 
• Gene edited pig kidney transplanted into a living patient for the first time
• Kidney Disease Statistics for the United States 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model. Jen is joined by Vynamic’s Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we’ve learned partnering with clients to build their omnichannel capabilities and what Life Sciences organizations can do to take their customer engagement to the next level.   

For more information on Vynamic’s work in Customer Experience Transformation, check out our service page:  

Podcast Tags: omnichannel, customer engagement, customer experience, marketing, healthcare, life sciences

Panel – Mike Zapiec, Josh Padams, Jen Burke

Research & Production – Hannah Yee, Aisling McAtamney, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe. 

Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain, supply chain 

Source Links: 

• UK lacks plans to make pandemic vaccines quickly, MPs hear 
• Spring Budget puts UK on fast-track to becoming science and technology superpower 
• UK Spring Budget allocates funds to life sciences manufacturing 
• £360 million to boost British manufacturing and R&D 
• ABPI response to the Budget 
• UK Chancellor trumpets £650m AstraZeneca investment 
• Meet the AI chatbot therapists filling the gaps in Europe’s mental health care shortfall 
• Mental health services facing ‘vicious cycle’ workforce issue 
• A chatbot helped more people access mental-health services 
• Closing the accessibility gap to mental health treatment with a personalized self-referral chatbot 
• A child in Poland has to wait 238 days to see a psychiatrist, activist says 
• From ‘crisis’ to ‘pandemic’: mental health in Europe 
• Europe\’s mental health crisis: Which country uses the most antidepressants? 
• Belgium leads the charge on the EU’s medicines reshoring plans 
• EU capitals propose Chips Act for medicines 
• Onshoring and global health – has the pandemic sent globalisation into reverse? 
• France\’s Emmanuel Macron seeks to relocate domestic production of key drugs to avoid shortages 
• Barcelona identified as Europe’s second-best hub for biotech investment 
• Moderna opens international centre for analytical excellence in Madrid 
• Spain showing great pharma potential as Barcelona named Europe’s No.2 hub for biotech investment 
• Spain Has All the Right Elements To Become a Fast-Growing Life Science Hub 
• Spain’s plan to become Europe’s pharmaceutical epicentre 

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Karan Pandya, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Health Plans, Saurabh Raman, to talk about the growth and challenges obesity medications present for the health industry.

Podcast Tags: healthcare, obesity, weight loss, diabetes, health services, health plans, life sciences  

Source Links: 

• What Is Ozempic and Why Is It Getting So Much Attention? 
• We Know Where New Weight Loss Drugs Came From, but Not Why They Work 
• What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know 
• Supply Updates about Wegovy
• The increase in appetite for obesity drugs 
• Demand for GLP-1 drugs is growing. Here\’s why payers are hesitant to cover them for weight loss 
• More than 4,000 ads for Ozempic-style drugs found running on Instagram and Facebook  
• Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs 
• Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that 
• Cost isn’t the only reason Medicare doesn’t cover Wegovy
• New marketing push by Ozempic and others sparks body-positive backlash 
• What You Need to Know About Compounded Versions of Popular Weight Loss Drugs 
• Novo antes up $16.5B to poach CDMO giant Catalent amid Wegovy surge  
• Wegovy, other GLP-1s could lower heart disease: Study  
• Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics  
• How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy  
• Novo Nordisk\’s Wegovy bonanza looms large in Denmark  
• Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion  
• Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect  
• Ozempic vs Wegovy 
• Obesity drug boom pushes Novo Nordisk shares to record high 
• Popular use of obesity drugs like Ozempic could change consumer habits 

Panel – Jen Burke, Mindy McGrath, Karen Baldry, Saurabh Raman 

Research & Production – Adrea Cope, Everly Petruzzelli 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.

For more perspective on the Inflation Reduction Act\’s impact on Life Sciences companies, check out Mindy’s article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceutical

Panel – Jen Burke, Mindy McGrath

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new report from Reuters that revealed the dramatic increase in new drug prices throughout 2023.

Podcast Tags: healthcare, healthcare news, IVF, embryos, supreme court, reproductive health, life sciences, health policy, inflation reduction act, CMS, medicare, medicaid, drug prices, pharmaceutical 

Source Links: 

• The science of IVF: What to know about Alabama\’s \’extrauterine children\’ ruling  
• Rare Diseases at FDA 
• Prices for new US drugs rose 35% in 2023, more than the previous year. 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke  

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention. 

Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden 

Source Links:

• We’re naming cancers all wrong, oncology leader says  
• Forget lung, breast or prostate cancer: why tumour naming needs to change 
• A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action 
• Measles in Europe: WHO calls for ‘urgent’ vaccinations as cases surge 
• Europe Needs to Get on Top of Its Measles Outbreak 
• Europe faces resurgence of measles due to low vaccination coverage 
• Europe\’s first transport of blood bags by drone takes place in Belgium 
• NHS to pioneer drone deliveries in bid to improve service 
• Drone chemotherapy becomes an NHS net zero cancer strategy 
• Sweden uses drones to fight cardiac arrest 
• Healthcare From Above: Challenges And Opportunities Of Medical Drones 
• Flight Trials for Scots Medicine-carrying Drones Conducted 
• Government to invest £30 million in innovative technology for NHS 
• Department of Health and Social Care: Medical Technology Strategy 
• Drones to deliver NHS medication to care homes and GP surgeries in major roll-out 
• NHS to begin delivering critical medical supplies by drone 

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Karan Pandya, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.

Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology 

Source Links: 

• The biggest stories from the 2024 J.P. Morgan Healthcare Conference 
• 5 medtech trends to watch in 2024 
• MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK 
• Medtronic aims to leverage medical device data for AI-enabled care 
• 4 heart device trends shaping the medtech sector in 2024 
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year 
• Boston Scientific nets Farapulse approval, pushes back US TAVR launch 
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year 
• Medtronic snags first pulsed field ablation approval in US 
• Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation 
• Increasing diabetes awareness boosts the diabetes care devices market 

Panel – Mary Virzi, Anila Patel, Jen Burke 

Research & Production – Adrea Cope, Everly Petruzzelli 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.

Check out Vynamic’s Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle. 

Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation 

Source Links: 

• Inizio Biotech key takeaways from JPM industry event 
• Cigna sells Medicare business to Health Care Service for $3.3 bln 
• Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics 
• J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree 
• Amazon rolls out digital health benefits program, taps Omada Health as launch partner 
• What the Health Care Sector Was Selling at the J.P. Morgan Confab 
• Jefferson Health says LVHN merger would double its insurance business within 2 years 

Panel – Jen Burke, Kevin Fletcher, Sean Martin 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and communicate the value of their work. In this deep dive episode, Jen is joined by Gemma Pfister, Head of Life Sciences Europe at Vynamic and Lori Klein, Partner, Medical & Scientific Affairs Practice Lead at Putnam, to discuss what leaders should be thinking about when it comes to measuring impact in Medical Affairs.

For more information about the work Putnam does in the Medical Affairs space, visit Putnam’s Medical & Scientific Affairs page. To learn more about Vynamic’s work in Medical Affairs, visit Vynamic’s Medical Affairs page. 

Podcast Tags: healthcare, life sciences, medical affairs, omnichannel, AI

Panel – Gemma Pfister, Jen Burke, Lori Klein

Research & Production – Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania\’s  innovation wave in biotech and MedTech.

Podcast Tags: healthcare, healthcare news, life sciences, obesity, medtech, sustainability, biotech, medtech, innovation, lithuania 

Source Links: 

• Excess mortality in England post COVID-19 pandemic: implications for secondary prevention 
• UK life expectancy falls to lowest level in a decade 
• Excess deaths involving cardiovascular disease: an analysis 
• Wegovy made available in the uk for weight loss in people with prediabetes and type 2 diabetes 
• Our response to serious supply issues of drugs for people with type 2 diabetes 
• Ministers launch £40m pilot scheme to trial wider access to slimming jab 
• Health Inequalities, Lives, Cut Short, January 2024 

• Can Denmark\’s world-beating drugs maker stay ahead? 
• Landmark report on reducing environmental impact of surgical care published 
• Green Surgery – Reducing the environmental impact of surgical care 
• Lithuania Set to Become Home to Largest Biotech City 
• Baltic-bound: is Lithuania desirable for EU life science investment? 

Panel –  Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young, Karan Pandya, Ollie May 

Recording & Editing – Mike Liberto, Rachel Skonecki  

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at  

1-888-VYNAMIC.

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deriving value, expanding their business models beyond dispensing prescription drugs to become wellness destinations. Mindy and Jen are joined by Health Services Heads of Sector, Saurabh Raman and Ryan Hummel, to discuss this complex industry and its evolution. 

For more information about the work discussed in this episode, check out  

Podcast Tags: healthcare, mergers & acquisitions, pharmacy, PBMs, pharmacists, specialty pharmacy, health services  

Source Links: 

• Market Insights: Pharmacies–Worldwide  
• The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending   
• Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead  
• Competition, Consolidation, and Evolution in the Pharmacy Market  
• CVS Pharmacy Downsizes: 10 Industry Trends Driving the Retail Shakeout  
• 2023 Forecast: Pharmacists push to take on a greater role in patient care  
• A new day in retail pharmacy: The evolving role of pharmacist  
• Five Trends Transforming Pharmacies into Wellness Centers of the Future  
• Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic 

• An Inside Look at Walgreens\’ primary care and pharmacy model 
• CVS Health completes acquisition of Oak Street Health  
• CVS launches new venture in biosimilar drug experiment  
• AMA: Don\’t expand scope of practice for already overworked pharmacists 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel, Saurabh Raman 

Research & Production – Adrea Cope, Everly Petruzzelli, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms.

Podcast Tags: healthcare, healthcare news, life sciences, mergers & acquisitions, radiopharma, medtech, artificial intelligence, antibiotics, health services, providers, private equity, hospitals 

Source Links: 

• BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public 
• ‘Explainable’ AI discovers new class of antibiotics that stop MRSA in mice 
• Discovery of a structural class of antibiotics with explainable deep learning 
• Serious Medical Errors Rose After Private Equity Firms Bought Hospitals  

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy implications & judicial decisions, 2) realizing the value of convergence, 3) healthcare as a service, 4) revolutionizing healthcare through AI tech, and 5) next-gen meds.

To learn more about Vynamic’s 2024 health industry outlook, visit https://vynamic.com/insights/2024-health-industry-outlook/

Podcast Tags: healthcare, healthcare news, healthcare trends 

Panel – Jen Burke, Karen Baldry, Mary Virzi, Mindy McGrath, Ryan Hummel, Saurabh Raman 

Research & Production – Jen Burke, Mindy McGrath 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Health Technology Mary Virzi to discuss the five MedTech trends Mary expects to be most impactful in 2024. These trends include 1) increased research & development spend, 2) embracing remote patient monitoring, 3) spinoffs to expand access, 4) global regulation and policy shifts, and 5) concentrated mergers and acquisitions.

To learn more about Vynamic’s perspective on MedTech, visit https://vynamic.com/insights/2024-medtech-outlook/

Podcast Tags: healthcare, healthcare news, health technology, medtech, healthcare trends

Panel – Mary Virzi, Jen Burke

Research & Production – Mary Virzi, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Life Sciences Karen Baldry to discuss the five Life Sciences trends Karen expects to be most impactful in 2024. These trends include 1) balancing innovation & affordability, 2) launching for value, 3) breaking down silos, 4) mastering omnichannel, and 5) integrating AI.

To learn more about Vynamic’s work in the Life Sciences sector, visit  https://vynamic.com/what-we-do/health-industry/life-sciences/ 

Podcast Tags: healthcare, healthcare news, life sciences, healthcare trends, healthcare innovation, product launch, omnichannel, AI 

Panel – Karen Baldry, Jen Burke 

Research & Production – Karen Baldry, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Jen is joined by members of Vynamic’s London office to unpack key insights from two recent conferences. First, Senior Executive Gemma Pfister and Director Nick Fletcher discuss the recent Evidence Life Science Medical Affairs Insights & Omnichannel Conference in London. Then, Senior Directors Jack Young and Owen Thomas cover the Next Pharma Customer Experience Summit in Vienna. Join us to stay ahead in the evolving world of omnichannel and customer experience, med affairs, and launch as our team shares expert perspectives, innovative strategies, and the latest trends shaping the Life Sciences industry. 

Podcast Tags: healthcare, healthcare news, life sciences, customer experience, medical affairs, omnichannel, patient centricity, digital transformation, nextpharmasummit, product launch  

Source Links: 

• From Excellent to Exceptional: The Power of Authenticity in Product Launch 
• Next Pharma Summit  

Panel – Gemma Pfister, Jack Young, Jen Burke, Nick Fletcher, Owen Thomas

Research & Production – Jack Young

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Payers Saurabh Raman to discuss the five Payer trends Saurabh expects to be most impactful in 2024. These trends include 1) product diversification and a strategic shift to government markets, 2) regulatory changes to Medicare, 3) improving care for enrollees with social risk factors, and 4) emphasizing value and putting the patient first.

To learn more about Vynamic’s work with Payers in the Health Services sector, visit https://vynamic.com/what-we-do/health-industry/health-services/#payers

Podcast Tags: healthcare, healthcare news, payers, health systems, health services, hospitals, healthcare trends 

Panel – Saurabh Raman, Jen Burke

Research & Production – Saurabh Raman, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we begin our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Providers Ryan Hummel to discuss the five Provider trends Ryan expects to be most impactful in 2024. These trends include 1) increased financial stability, 2) digitizing the patient experience, 3) accelerating health equity progress with partnerships, 4) creating the workforce of the future, and 5) a changing competitive landscape.

To learn more about Vynamic’s work with Providers in the Health Services sector, visit .

Podcast Tags: healthcare, healthcare news, providers, health systems, hospitals, healthcare trends

Panel – Ryan Hummel, Jen Burke 

Research & Production – Ryan Hummel, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Deals, mergers, partnerships, and acquisitions are key mechanisms as health organizations look to enter new markets, differentiate their value proposition, and achieve growth strategies. Despite a less than favorable economic environment, the health industry has seen some major headlines in this space this year. Jen and Mindy are joined by Vynamic’s Deal Activation & Partnership Enablement Service Leads, Sean Martin and Kevin Fletcher, to discuss what’s driving these deals and what health industry leaders should be thinking about to maximize their value.

For more information about the work discussed in this episode, visit https://vynamic.com/what-we-do/services/deal-activation-partnership-enablement/

Podcast Tags: healthcare, healthcare news, mergers, acquisitions, deal activation, partnerships, health services, payers, providers, life sciences 

Source Links:

• Optimistic outlook for deals through 2023 
• M&A and venture trends in life sciences in 2023 
• A Look at Q2 M&A and Beyond: Are Conditions Ripe for a Strong 2024 M&A Rebound? 
• The Kaiser Permanente-Geisinger deal: Questions and answers 
• CVS closed $8B deal for health services company Signify Health 
• Pfizer buys Seagen for $43B, boosts access to cancer drugs 
• Amgen completes $27.8 billion Horizon Therapeutics deal 

Panel – Sean Martin, Kevin Fletcher, Mindy McGrath, Jen Burke

Research & Production – Adrea Cope, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Payer organizations are betting big on government markets, with some abandoning commercial opportunities entirely. In this episode, Jen is joined by two leaders in Vynamic\’s Health Services sector, Executive Saurabh Raman and Senior Director Keith Sutter to explore what this trend means for the health industry, the complexities involved in these markets, and the steps payers can take to guarantee success.  

For more information about the work discussed in this episode, check out https://vynamic.com/what-we-do/health-industry/health-services/ 

Podcast Tags: healthcare, healthcare news, health plans, CMS, Medicare, Medicaid  

Source Links: 

• Medicare Advantage in 2023: Enrollment Update and Key Trends  
• The Employer Strikes Back: The Hollowing of the Commercial Health Insurance Market and Its Impact on Payers and Providers 
• Medicare Advantage\’s growth spurt brings tensions 
• The subtle privatization of Medicare 
• Expanding Medicare Advantage could address \’fragmented\’ care for dual-enrolled individuals 
• 10 Things to Know About the Unwinding of the Medicaid Continuous Enrollment Provision 
• A Profile of Medicare-Medicaid Enrollees (Dual Eligibles) 
• CMS Shared Savings Program In the News 
• Medicare Shared Savings Program Saves Medicare More Than $1.8 Billion in 2022 and Continues to Deliver High-quality Care  

Panel – Keith Sutter, Saurabh Raman, Jen Burke 

Research & Production –Marc Young, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Mindy and Jen catch up on the impact that the Inflation Reduction Act has had on the health industry over the last year and look ahead to how life sciences organizations, payors, and providers can prepare for the changes that this legislation will cause.  

If you missed our initial coverage of the Inflation Reduction Act, check out our Trending News episode from August 18, 2022.  

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, payors, providers, Medicare, drug prices 

Source Links: 

• Biden-Harris Administration Moves Forward with Medicare Drug Price Negotiations to Lower Prescription Drug Costs for People with Medicare 
• U.S. Announces First Drugs Picked for Medicare Price Negotiations 
• On the First Anniversary of the Inflation Reduction Act, Millions of Medicare Enrollees See Savings on Health Care Costs 
• Understanding the Health Provisions in the Inflation Reduction Act 
• Inflation Reduction Act and Medicare 

Panel – Jen Burke, Mindy McGrath

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The growth of the biotech industry has become a recurring topic on Trending Health episodes, from headlines about Novo Nordisk products Ozempic and Wegovy, to the emergence of Moderna as a household name thanks to their mRNA COVID-19 vaccine. As more biotech companies emerge into the market, they bring with them a mix of challenges and opportunities. On this episode of Trending Health, Jen and Mindy are joined by special guest, Dean McAlister, EVP of Inizio Biotech, to discuss the latest headlines and stories from the biotech sector.

For more information about the work discussed in this episode & Inizio Biotech, check out “The Phase II Inflection Point: Investing to Maximize Asset Value”.

Podcast Tags: healthcare, healthcare news, life sciences, biotech

Panel – Dean McAlister, Jen Burke, Mindy McGrath

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The global medical device market is expected to grow at a compound rate of nearly 5% in the next few years – fueled by a forecasted uptick in product launches. On this episode, Jen is joined by Vynamic\’s Head of Health Technology Sector Mary Virzi and Senior Manager Christina Nikolos, to discuss how MedTech companies should approach launch to capitalize on this opportunity.

For information about how Vynamic can support Med and Health tech companies preparing for launch, visit vynamic.com/what-we-do/health-industry/health-technology/

Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology

Source Links:

• Special Report—The top 10 medtech companies of 2024 
• MedTech Industry Trends 2023 – What\’s the Future? 
• The 10 most innovative medical device companies of 2023 
• Medical devices and pharmaceuticals: Two different worlds in one health setting 
• Future of medtech: Build resilience, deliver value 
• MedTech is going consumer; capturing the opportunity requires a new approach  
• The Future of MedTech Defined by Healthcare Consumerism
• Value-centricity is key for MedTech to become a strategic partner to customers  

Panel – Mary Virzi, Christina Nikolos, Jen Burke

Research & Production – Adrea Cope, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Cell and gene therapies present an enormous opportunity for patients – the ability to insert or adapt genetic material is a true breakthrough for precision medicine and brings hope to those with previously incurable diseases. However, bringing these therapies to patients comes with enormous complexity – from research and approval through manufacturing and administration. In this episode, Jen and Mindy are joined by special guests Karen Baldry and Rebecca Sisselman to discuss the opportunities cell and gene therapies present, the challenges industry partners may be facing, and key considerations for navigating towards success.

For a recent example of Vynamic’s work in cell and gene therapy, check out our case study “Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy (CGT) Biotech”  

Podcast Tags: healthcare, life sciences, cell and gene therapy, gene therapy, rare disease, drug launch 

Source Links: 

• Eight imperatives for launching cell and gene therapies 
• Why Integrated Partners are Critical to Cell and Gene Therapy Success 
• Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Panel – Karen Baldry, Rebecca Sisselman, Mindy McGrath, Jen Burke 

Research & Production – Marc Young, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent EU-based newsworthy items, including the importance of ethnicity data and its impact on healthcare systems (0.35), exciting and emerging retail health opportunities (8.08), and a landmark report calling for urgent investment in digital health literacy (16.20).

Podcast Tags: healthcare, healthcare news, life sciences, ethnicity, DEI, WHO, Retail Health, Digital, Digital Health, health policy, public health 

Source Links: 

• Hidden in plain sight: addition of race and ethnicity improves clinical algorithm performance 
• The problem with ethnicity categories in UK health data 
• How can we make better use of ethnicity data to improve healthcare services? 
• Healthcare AI Caution: Addressing ethnic health inequalities 
• How can we make better use of ethnicity data to improve healthcare services? 
• AI in healthcare could exacerbate ethnic and income inequalities, scientists warn 
• The health of people from ethnic minority groups in England 
• Understanding consistency of ethnicity data recorded in health-related administrative datasets in England: 2011 to 2021 
• One-stop shop: Where healthcare meets retail 
• Retail Healthcare Continues to Consolidate in Europe 
• Boots boss calls for data sharing between pharmacies and the NHS 
• The Future of Retail Health and the New Healthcare Experience 
• UK public becoming more comfortable with healthcare in retail settings 
• High Street giant Boots is taking digital healthcare to the people 
• Many people on Medicare lack internet access and digital literacy, and it’s harming their health. How some groups are addressing the problem 
• Statement – We are on the cusp of a digital health revolution yet millions risk being left behind 
• Digital health divide: only 1 in 2 countries in Europe and central Asia have policies to improve digital health literacy, leaving millions behind
• Millions left behind by a lack of regulation on improving digital health literacy 
• WHO Europe Calls for Urgent Investment in Digital Health Literacy 
• Safety of telehealth and digital health services is being neglected, says WHO Europe 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young, Karan Pandya, Ollie May 

Recording & Editing – Mike Liberto, Rachel Skonecki  

For additional discussion, please contact us atTrendingHealth.comor share a voicemail at

1-888-VYNAMIC.